The ups and downs of motion sickness

American Journal of Nursing

Volumn 110, Issue 12, 2010, Pages 49-51

  Herron, Dorothy G ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; MOTION SICKNESS; PATHOPHYSIOLOGY;

HUMANS; MOTION SICKNESS;

EID: 78650376711     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000391242.75887.17     Document Type: Article

References (22)

1. [No authors listed]. Committee to advise on tropical medicine and travel (CATMAT). Statement on motion sickness. Can Commun Dis Rep 1996;22(13):101-11.
2. Jennings RT. Managing space motion sickness. J Vestib Res 1998;8(1):67-70.
3. Yates BJ, et al. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998;47(5):395-406.
4. Eisenman LM. Motion sickness may be caused by a neurohumoral action of acetylcholine. Med Hypotheses 2009; 73(5):790-3.
5. Muth ER, et al. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness. Aviat Space Environ Med 1995;66(11):1041-5.
6. Schmid R, et al. Comparison of seven commonly used agents for prophylaxis of seasickness. J Travel Med 1994; 1(4):203-6.
7. Takeda N, et al. Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats. Methods Find Exp Clin Phar macol 1995;17(9):589-90.
8. Estrada A, et al. Airsickness prevention in helicopter passengers. Aviat Space Environ Med 2007;78(4):408-13.
9. Buckey JC, et al. Chlorpheniramine for motion sickness. J Vestib Res 2004;14(1):53-61.
10. Spinks AB, et al. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 2007(3):CD002851.
11. Nachum Z, et al. Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2006;45(6):543-66.
12. Alhalel A, et al. Ocular effects of hyoscine in double dose transdermal administration and its reversal by low dose pyridostigmine. Aviat Space Environ Med 1995;66(11):1037-40.
13. Mowrey DB, Clayson DE. Motion sickness, ginger, and psychophysics. Lancet 1982;1(8273):655-7.
14. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 2000;84(3):367-71. (Pubitemid 30114135)
15. Jiang X, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59(4):425-32.
16. Jokerst MD, et al. Slow deep breathing prevents the development of tachygastria and symptoms of motion sickness. Aviat Space Environ Med 1999;70(12):1189-92.
17. Levine ME, et al. Protein-predominant meals inhibit the development of gastric tachyarrhythmia, nausea and the symptoms of motion sickness. Aliment Pharmacol Ther 2004; 19(5):583-90.
18. Fan CF, et al. Acupressure treatment for prevention of postoperative nausea and vomiting. Anesth Analg 1997;84(4): 821-5.
19. Vente PE, et al. Motion sickness amelioration induced by prism spectacles. Brain Res Bull 1998;47(5):503-5.
20. Gahlinger PM. Cabin location and the likelihood of motion sickness in cruise ship passengers. J Travel Med 2000;7(3): 120-4.
21. Mills KL, Griffin MJ. Effect of seating, vision and direction of horizontal oscillation on motion sickness. Aviat Space Environ Med 2000;71(10):996-1002.
22. Cowings PS, Toscano WB. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms. J Clin Pharmacol 2000;40(10):1154-65.